Cartilage regeneration: clinical progress and future outlook

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Orthopedics

Background:

• Articular cartilage degeneration, common in osteoarthritis, has limited repair capacity due to its avascular nature and sparse chondrocytes.
• Current therapies often manage symptoms but fail to restore durable cartilage architecture.
• Advances are shifting focus towards mechanism-based cartilage regeneration.

Purpose of the Study:

• To review emerging clinical evidence for various cartilage regeneration strategies.
• To emphasize the importance of integrated, multimodal approaches for durable repair.
• To highlight the need for standardized outcome measures in clinical trials.

Main Methods:

• Review of emerging clinical evidence across cell-based strategies, biomaterial- and scaffold-assisted repair, biologics, and combination approaches.
• Assessment of current therapeutic limitations and future directions in cartilage repair.
• Emphasis on integrated treatment modalities and standardized outcome assessment.

Main Results:

• Cell-based therapies, engineered scaffolds, and biologics show promise for cartilage regeneration.
• Multimodal and combination approaches are increasingly important for effective repair.
• Standardized clinical endpoints are crucial for evaluating treatment efficacy and disease modification.

Conclusions:

• Integrated, multimodal strategies are essential for achieving durable cartilage repair.
• Standardized outcome measures are critical for advancing the field of cartilage regeneration.
• The future of osteoarthritis treatment lies in mechanism-based regeneration for true disease modification.